No black box warning on record for Yorvipath
As of the latest FDA labeling reviewed, Yorvipath (PALOPEGTERIPARATIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Yorvipath medicine page for the complete safety profile.